Clinical Trial Update: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and bioequivalence comparison of empagliflozin/metformin hydrochloride 5 mg/1000 mg tablets from Gedeon Richter versus Synjardy (empagl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin + Metformin hydrochloride combination tablet (empagliflozin/metformin)
• SYNJARDY (empagliflozin and metformin hydrochloride)

Snippet

Sponsor: Gedeon Richter Plc. | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED